Order Article Reprints

Laane E, Salek S, Oliva EN, Bennink C, Clavreul S, Richardson PG, Scheid C, Weisel K, Ionova T on behalf of the European Hematology Association Specialized Working Group on Quality of Life and Symptoms. Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials. Cancers. 2023; 15(24):5764. https://doi.org/10.3390/cancers15245764

Laane, Edward, Sam Salek, Esther Natalie Oliva, Christine Bennink, Solène Clavreul, Paul G Richardson, Christof Scheid, Katja Weisel, and Tatyana Ionova on behalf of the European Hematology Association Specialized Working Group on Quality of Life and Symptoms. 2023. "Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials" Cancers 15, no. 24: 5764. https://doi.org/10.3390/cancers15245764

Laane, E., Salek, S., Oliva, E. N., Bennink, C., Clavreul, S., Richardson, P. G., Scheid, C., Weisel, K., & Ionova, T., on behalf of the European Hematology Association Specialized Working Group on Quality of Life and Symptoms. (2023). Guidelines for the Use and Reporting of Patient-Reported Outcomes in Multiple Myeloma Clinical Trials. Cancers, 15(24), 5764. https://doi.org/10.3390/cancers15245764